Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 May;61(5):759–762. doi: 10.1038/bjc.1990.169

Ploidy as a prognostic indicator in end stage squamous cell carcinoma of the head and neck region treated with cisplatinum.

L D Cooke 1, T G Cooke 1, F Bootz 1, G Forster 1, T R Helliwell 1, D Spiller 1, P M Stell 1
PMCID: PMC1971589  PMID: 2337512

Abstract

We measured tumour cellular DNA in 102 patients entered into two phase III trials of chemotherapy for end stage squamous carcinoma of the head and neck. The median survival of untreated patients with aneuploid tumours was 55 days compared with 224 days for patients treated with cisplatinum. This difference was highly significant. In contrast the median survival of untreated patients with diploid tumours was 74 days compared with 118 days for treated patients. Although this difference is statistically significant, the increased survival of 6 weeks is of no clinical benefit compared with the prolongation of survival of 6 months in patients with aneuploid tumours. Multivariate analysis showed that the significant predictors of survival were Karnofsky status, response to chemotherapy and ploidy.

Full text

PDF
759

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armitage N. C., Robins R. A., Evans D. F., Turner D. R., Baldwin R. W., Hardcastle J. D. The influence of tumour cell DNA abnormalities on survival in colorectal cancer. Br J Surg. 1985 Oct;72(10):828–830. doi: 10.1002/bjs.1800721018. [DOI] [PubMed] [Google Scholar]
  2. Barlogie B., Raber M. N., Schumann J., Johnson T. S., Drewinko B., Swartzendruber D. E., Göhde W., Andreeff M., Freireich E. J. Flow cytometry in clinical cancer research. Cancer Res. 1983 Sep;43(9):3982–3997. [PubMed] [Google Scholar]
  3. Barlogie B., Stass S., Dixon D., Keating M., Cork A., Trujillo J. M., McCredie K. B., Freireich E. J. DNA aneuploidy in adult acute leukemia. Cancer Genet Cytogenet. 1987 Oct;28(2):213–228. doi: 10.1016/0165-4608(87)90207-x. [DOI] [PubMed] [Google Scholar]
  4. Campbell J. B., Dorman E. B., Helliwell T. R., McCormick M., Miles J., Morton R. P., Rugman F., Stell P. M., Stoney P. J., Vauhan E. D. Factors predicting response of end stage squamous cell carcinoma of the head and neck to cisplatinum. Clin Otolaryngol Allied Sci. 1987 Jun;12(3):167–176. doi: 10.1111/j.1365-2273.1987.tb00183.x. [DOI] [PubMed] [Google Scholar]
  5. Cornelisse C. J., van de Velde C. J., Caspers R. J., Moolenaar A. J., Hermans J. DNA ploidy and survival in breast cancer patients. Cytometry. 1987 Mar;8(2):225–234. doi: 10.1002/cyto.990080217. [DOI] [PubMed] [Google Scholar]
  6. Ensley J. F., Maciorowski Z., Hassan M., Pietraszkiewicz H., Heilbrun L., Kish J. A., Tapazoglou E., Jacobs J. R., al-Sarraf M. Cellular DNA content parameters in untreated and recurrent squamous cell cancers of the head and neck. Cytometry. 1989 May;10(3):334–338. doi: 10.1002/cyto.990100313. [DOI] [PubMed] [Google Scholar]
  7. Feichter G. E., Maier H., Adler D., Born I. A., Abel U., Haag D., Goerttler K. S-phase fractions and DNA-ploidy of oropharyngeal squamous epithelium carcinomas compared with histologic grade, stage, response to chemotherapy and survival. Acta Otolaryngol. 1987 Sep-Oct;104(3-4):377–384. doi: 10.3109/00016488709107343. [DOI] [PubMed] [Google Scholar]
  8. Fordham M. V., Burdge A. H., Matthews J., Williams G., Cooke T. Prostatic carcinoma cell DNA content measured by flow cytometry and its relation to clinical outcome. Br J Surg. 1986 May;73(5):400–403. doi: 10.1002/bjs.1800730530. [DOI] [PubMed] [Google Scholar]
  9. Franzén G., Klintenberg C., Olofsson J., Risberg B. DNA measurement--an objective predictor of response to irradiation? A review of 24 squamous cell carcinomas of the oral cavity. Br J Cancer. 1986 May;53(5):643–651. doi: 10.1038/bjc.1986.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Goldsmith M. M., Cresson D. H., Arnold L. A., Postma D. S., Askin F. B., Pillsbury H. C. DNA flow cytometry as a prognostic indicator in head and neck cancer. Otolaryngol Head Neck Surg. 1987 Apr;96(4):307–318. doi: 10.1177/019459988709600402. [DOI] [PubMed] [Google Scholar]
  11. Hedley D. W., Friedlander M. L., Taylor I. W., Rugg C. A., Musgrove E. A. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983 Nov;31(11):1333–1335. doi: 10.1177/31.11.6619538. [DOI] [PubMed] [Google Scholar]
  12. Holm L. E. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope. 1982 Sep;92(9 Pt 1):1064–1069. [PubMed] [Google Scholar]
  13. Holm L. E., Jakobsson P., Killander D., Silfverswärd C., Wersäll J. DNA and its synthesis in individual tumor cells from human upper respiratory tract squamous cell carcinomas. Laryngoscope. 1980 Jul;90(7 Pt 1):1209–1224. doi: 10.1288/00005537-198007000-00017. [DOI] [PubMed] [Google Scholar]
  14. Jakobsen A. Prognostic impact of ploidy level in carcinoma of the cervix. Am J Clin Oncol. 1984 Oct;7(5):475–480. doi: 10.1097/00000421-198410000-00016. [DOI] [PubMed] [Google Scholar]
  15. Joensuu H., Klemi P., Eerola E., Tuominen J. Influence of cellular DNA content on survival in differentiated thyroid cancer. Cancer. 1986 Dec 1;58(11):2462–2467. doi: 10.1002/1097-0142(19861201)58:11<2462::aid-cncr2820581119>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  16. Johnson T. S., Williamson K. D., Cramer M. M., Peters L. J. Flow cytometric analysis of head and neck carcinoma DNA index and S-fraction from paraffin-embedded sections: comparison with malignancy grading. Cytometry. 1985 Sep;6(5):461–470. doi: 10.1002/cyto.990060511. [DOI] [PubMed] [Google Scholar]
  17. Kaplan A. S., Caldarelli D. D., Chacho M. S., Bruce D. R., Hutchinson J., Conway S., Coon J. S. Retrospective DNA analysis of head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg. 1986 Nov;112(11):1159–1162. doi: 10.1001/archotol.1986.03780110035003. [DOI] [PubMed] [Google Scholar]
  18. Kokal W. A., Gardine R. L., Sheibani K., Zak I. W., Beatty J. D., Riihimaki D. U., Wagman L. D., Terz J. J. Tumor DNA content as a prognostic indicator in squamous cell carcinoma of the head and neck region. Am J Surg. 1988 Oct;156(4):276–280. doi: 10.1016/s0002-9610(88)80291-5. [DOI] [PubMed] [Google Scholar]
  19. Look A. T., Hayes F. A., Nitschke R., McWilliams N. B., Green A. A. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med. 1984 Jul 26;311(4):231–235. doi: 10.1056/NEJM198407263110405. [DOI] [PubMed] [Google Scholar]
  20. Look A. T., Roberson P. K., Williams D. L., Rivera G., Bowman W. P., Pui C. H., Ochs J., Abromowitch M., Kalwinsky D., Dahl G. V. Prognostic importance of blast cell DNA content in childhood acute lymphoblastic leukemia. Blood. 1985 May;65(5):1079–1086. [PubMed] [Google Scholar]
  21. Matsuura H., Sugimachi K., Ueo H., Kuwano H., Koga Y., Okamura T. Malignant potentiality of squamous cell carcinoma of the esophagus predictable by DNA analysis. Cancer. 1986 May 1;57(9):1810–1814. doi: 10.1002/1097-0142(19860501)57:9<1810::aid-cncr2820570917>3.0.co;2-j. [DOI] [PubMed] [Google Scholar]
  22. Miller A. B., Hoogstraten B., Staquet M., Winkler A. Reporting results of cancer treatment. Cancer. 1981 Jan 1;47(1):207–214. doi: 10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  23. Morton R. P., Rugman F., Dorman E. B., Stoney P. J., Wilson J. A., McCormick M., Veevers A., Stell P. M. Cisplatinum and bleomycin for advanced or recurrent squamous cell carcinoma of the head and neck: a randomised factorial phase III controlled trial. Cancer Chemother Pharmacol. 1985;15(3):283–289. doi: 10.1007/BF00263902. [DOI] [PubMed] [Google Scholar]
  24. Tytor M., Franzén G., Olofsson J. DNA pattern in oral cavity carcinomas in relation to clinical stage and histological grading. Pathol Res Pract. 1987 Apr;182(2):202–206. doi: 10.1016/S0344-0338(87)80105-X. [DOI] [PubMed] [Google Scholar]
  25. Tytor M., Franzén G., Olofsson J. DNA ploidy in oral cavity carcinomas, with special reference to prognosis. Head Neck. 1989 May-Jun;11(3):257–263. doi: 10.1002/hed.2880110312. [DOI] [PubMed] [Google Scholar]
  26. Zimmerman P. V., Hawson G. A., Bint M. H., Parsons P. G. Ploidy as a prognostic determinant in surgically treated lung cancer. Lancet. 1987 Sep 5;2(8558):530–533. doi: 10.1016/s0140-6736(87)92923-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES